 The study reveals that Lipol-1-DT, a protective LNCRNA, inhibits the proliferation metastasis of triple negative breast cancer, TNBC, cells by restraining the aberrant reactivation of the WN slash beta-cadenin signaling pathway through interaction with heterogeneous nuclear ribonucleoprotein K, HN-RNPK. This article was authored by Yu Hui-Tang, Wen Wen-Tian, Xiao Kuan-Jing, and others.